Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
about
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancerNovel role for PDEF in epithelial cell migration and invasionA collection of breast cancer cell lines for the study of functionally distinct cancer subtypesTranscriptional control of cancer metastasisETS-4 is a transcriptional regulator of life span in Caenorhabditis elegansSPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus productionElf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progressionProstate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.Requirement of the epithelium-specific Ets transcription factor Spdef for mucous gland cell function in the gastric antrum.SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent MechanismsMechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.Ets proteins in biological control and cancer.Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.PDEF is a negative regulator of colon cancer cell growth and migrationGene expression of circulating tumour cells in breast cancer patientsProstate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancerThe transcription factor SPDEF suppresses prostate tumor metastasisIdentification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells.PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells.SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.Master regulators of FGFR2 signalling and breast cancer riskMicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.A novel role for Ets4 in axis specification and cell migration in the spider Parasteatoda tepidariorum.High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lungLoss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells.Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites.Gene signature driving invasive mucinous adenocarcinoma of the lung.ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and CancerAR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer
P2860
Q24306191-8F78AEDD-15A2-464D-8C3C-DAB2831D960AQ24633487-D608825C-FF5F-482D-B8B3-BE0746086A3AQ24647928-D95E20F6-0372-4856-937B-207BAD35F735Q26992024-E8404D9B-2184-43C8-BD32-45FBB00363F5Q27346260-AB34C603-067F-4450-BC0A-C76B802A07F3Q28507392-AA041AFC-F077-42C5-8925-27E85C0AE461Q29042375-D58574F0-FAFE-4032-961B-ED609D8F2EC2Q30156863-88E11CF0-7FAB-40F7-B158-BE1227568301Q30157655-2FC47C3A-AAA1-442B-81BA-5C08DA70C45DQ33652494-3EFA9316-E29F-4D35-B830-43B4EAABC815Q33681985-AC29490E-B273-4016-8974-259801D37DA5Q33799676-F8362DF4-AF37-429A-AE61-B1AECAEB0D10Q34251439-847FBF1F-2DAC-4006-A8D8-38DA717BB1B4Q34257025-E2F40804-C3F6-41A9-B13D-3AF550356F79Q34417579-2925E69A-E8E4-4F1E-BE2F-845810712D37Q35034883-39BE4112-1D7B-41FE-A728-065D816A96A0Q35082366-8F6F98B9-1511-4941-A066-88526822C974Q35701558-36BEDBD8-2902-41D2-AC5D-6BC8E8E92722Q35758944-AAD088E1-E1B0-4CDA-8179-F2AC8FD4C7F0Q35948104-4A84B832-86C5-49E8-A258-300F8438579BQ35960074-631886FD-1C09-498D-A225-0309F2F2CFB6Q36088622-E8A54608-BACD-47FC-AE77-CF5EBD6C3647Q36215965-B304CDDA-E19B-4F1D-9A34-D0149D0E960EQ36229602-2778BD97-A3B6-4BC3-9FBC-E2F0DBA0E093Q36238784-245FD24B-02AD-4720-AA70-42D2CF37AAEBQ36796922-A59BFEB8-C1AD-40FD-A1E6-A08C5C4B5F83Q37011750-4AC5EFE8-CCC3-4EAF-8D38-1D02C3817A4AQ37081755-76D88B34-91BF-40B9-B037-58E0DE9C419EQ37186448-4DA0BA37-026C-4755-83E3-4EE71842F312Q37187930-4478FD0B-0352-4660-908D-311D7E151A6FQ37355527-E457F5A3-D100-4A16-BDFB-59C2BB5DBD0BQ38367939-7BC36678-24B9-490B-A7C9-BE299CB81708Q39315640-BF7B1786-CA27-4579-99CF-DEA5EC16A476Q39692770-1DB83D71-F515-408A-9C83-94A5E5A6B8D4Q39794269-1C395316-7431-4AF9-95D0-CBC9C83EC29CQ41592766-50CED932-0BEC-4E38-B286-6E266AF26563Q41879970-1F844F85-142D-4E04-8523-3B311DA70189Q42293061-BC5B0F39-1E30-4954-B055-0CB1B2F0C368Q58696663-F7B1C982-BFB4-4581-981D-0AD8AEE761F8Q58740515-276472BE-19AF-4D0A-B42E-C6244ABA7FC8
P2860
Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pdef expression in human breas ...... l and altered gene expression.
@ast
Pdef expression in human breas ...... l and altered gene expression.
@en
Pdef expression in human breas ...... l and altered gene expression.
@nl
type
label
Pdef expression in human breas ...... l and altered gene expression.
@ast
Pdef expression in human breas ...... l and altered gene expression.
@en
Pdef expression in human breas ...... l and altered gene expression.
@nl
prefLabel
Pdef expression in human breas ...... l and altered gene expression.
@ast
Pdef expression in human breas ...... l and altered gene expression.
@en
Pdef expression in human breas ...... l and altered gene expression.
@nl
P2093
P1433
P1476
Pdef expression in human breas ...... al and altered gene expression
@en
P2093
Dennis K Watson
Maged Gayed
Mostafa M Fraig
Ron J Feldman
Victor I Sementchenko
P304
P407
P577
2003-08-01T00:00:00Z